Omega Diagnostics Statistics
Omega Diagnostics (RVKA) Stock Statistics & Valuation Metrics
Total Valuation
Omega Diagnostics has a market cap or net worth of EUR 3.99M. The enterprise value is EUR 1.93M.
- Market Cap
- EUR 3.99M
- Enterprise Value
- EUR 1.93M
Share Statistics
Omega Diagnostics has 237,950,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 237,950,650
- Owned by Insiders
- 0.65%
- Owned by Institutions
- ―
Financial Efficiency
Omega Diagnostics’s return on equity (ROE) is -1.03 and return on invested capital (ROIC) is -17.76%.
- Return on Equity (ROE)
- -1.03
- Return on Assets (ROA)
- -0.78
- Return on Invested Capital (ROIC)
- -17.76%
- Return on Capital Employed (ROCE)
- -0.18
- Revenue Per Employee
- 82.06K
- Profits Per Employee
- -68.54K
- Employee Count
- 85
- Asset Turnover
- 0.94
- Inventory Turnover
- 4.12
Valuation Ratios
The current PE Ratio of Omega Diagnostics is -0.53. Omega Diagnostics’s PEG ratio is -0.01.
- PE Ratio
- -0.53
- PS Ratio
- 0.61
- PB Ratio
- 0.68
- Price to FCF
- -3.87
- Price to Operating Cash Flow
- -4.30
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Omega Diagnostics had revenue of 6.97M and earned -5.83M in profits. Earnings per share was -0.02.
- Revenue
- 6.97M
- Gross Profit
- 4.28M
- Operating Income
- -1.04M
- Pretax Income
- -4.42M
- Net Income
- -5.83M
- EBITDA
- -392.00K
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -774.00K and capital expenditures -86,000, giving a free cash flow of -860.00K billion.
- Operating Cash Flow
- -774.00K
- Free Cash Flow
- -860.00K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Omega Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -24.93%
- Earnings Yield
- -180.42%
Stock Price Statistics
- Beta
- 0.58
- 52-Week Price Change
- -29.41%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 28.90
- Average Volume (3m)
- ―
Important Dates
Omega Diagnostics upcoming earnings date is Sep 14, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 10, 2026
- Next Earnings Date
- Sep 14, 2027
- Ex-Dividend Date
- ―
Financial Position
Omega Diagnostics as a current ratio of 3.40, with Debt / Equity ratio of 2.20%
- Current Ratio
- 3.40
- Quick Ratio
- 3.00
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 6.41
- Interest Coverage Ratio
- -80.38
Taxes
In the past 12 months, Omega Diagnostics has paid 1.41M in taxes.
- Income Tax
- 1.41M
- Effective Tax Rate
- -0.32
Enterprise Valuation
Omega Diagnostics EV to EBITDA ratio is -1.35, with an EV/FCF ratio of -1.97.
- EV to Sales
- 0.31
- EV to EBITDA
- -1.35
- EV to Free Cash Flow
- -1.97
- EV to Operating Cash Flow
- -2.19
Balance Sheet
Omega Diagnostics has EUR 1.93M in cash and marketable securities with EUR 175.00K in debt, giving a net cash position of EUR 1.76M billion.
- Cash & Marketable Securities
- EUR 1.93M
- Total Debt
- EUR 175.00K
- Net Cash
- EUR 1.76M
- Net Cash Per Share
- EUR 0.01
- Tangible Book Value Per Share
- EUR 0.02
Margins
Gross margin is 60.96%, with operating margin of -28.90%, and net profit margin of -113.78%.
- Gross Margin
- 60.96%
- Operating Margin
- -28.90%
- Pretax Margin
- -88.08%
- Net Profit Margin
- -113.78%
- EBITDA Margin
- -22.88%
- EBIT Margin
- -28.90%
Analyst Forecast
The average price target for Omega Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -33.83%
- EPS Growth Forecast
- -536.23%
